Podcast: Play in new window | Download
Today’s episode follows Austin Regional Clinic (ARC), a large multi-specialty medical group that serves over 500,000 patients in Austin, Texas. Founded in 1980 as an HMO, ARC is coming full-circle on their journey in value-based care as they now serve more than half of their population in value-based contracts.
Tyler Willson, VP of Population Health and Clinical Quality talks with us about the tipping point for value, ARC’s strategy during and post-COVID, as well as partnerships with payers. We also explore Austin’s unique market where corporate giants like Apple, Tesla, Amazon, and IBM are turning the area into a hub for innovation, which offers a unique opportunity for ARC. Find out what will happen with Medicare Advantage plans in the market, how analytics and automation are enhancing care, and how an important partner is making it all possible for ARC to be a leader in the race to value.
Bookmarks:
4:01 Reaching the financial tipping point in health value
5:24 Austin Regional Clinic’s value-based care journey
8:28 Tyler describes ARC’s current population health infrastructure
9:08 The shift of payment environment towards full- and delegated-risk models
10:25 Sourcing capital and investments to build infrastructure
10:45 JV with Agilon Health (a PE-backed company that supports ARC in taking fully delegated, capitated risk in Medicare Advantage)
11:35 Evaluating the landscape to determine strategic planning horizon, scope, and scale for VBC portfolio
12:00 How the increased level of involuntary risk will necessitate strategic investments in enhanced care models
12:35 Lessons from COVID-19 in determining the “true” risk in ARC’s revenue portfolio
13:40 Shared Savings are critical lifelines in the COVID era
14:40 Austin, TX as an emerging national innovation hub
16:04 “so much of an organization’s capacity for innovation comes from what it believes”
17:00 Competition for workforce talent in Austin
17:30 How to design and implement patient satisfaction surveys to collect meaningful data
18:53 Austin as an “innovate or die” type market
19:35 An outline of poor public health measures in the state of Texas
21:04 ARC’s commitment to patient access as a bedrock principle
24:05 ARC’s holding true to its value proposition during the pandemic crisis
25:11 Ensuring patient access to telehealth
26:00 Creating a patient-centered care medical home by focusing on patient access
27:10 An overview of ARC’s quality measure performance
29:00 ARC’s focus on automation, predictive analytics, and extensive outreach to ensure successful closure of care gaps
33:45 The use of ML and NLP in algorithms to drive automation in burden of illness documentation
36:22 Predictive analytics as the “unicorn of our industry”
38:00 Development of a Medicare Advantage strategy in partnership with Agilon
41:30 Incubating the types of infrastructure to test innovation viability for managing full-risk MA
42:31 The importance of an investment partner in ARC’s expansion of its full-risk MA portfolio
43:00 Market growth of Medicare Advantage being driven by consumer price sensitivity
45:00 Capturing accurate documentation in the burden of illness to the highest level of specificity
46:30 Advocating for CMS to include audio-only visits as a means to document and revalidate HCC codes
49:30 An overview of ARC’s participation in Medicare ACO program with Ascension Seton
50:58 Evaluation of the Direct Contracting ACO model
53:50 Employer-physician collaboration to deliver quality care
Comments are closed.